stockrowNeuroOne Medical Technologies Corporation
NMTC Healthcare Medical Devices
NeuroOne Medical Technologies Corporation’s revenue for fiscal 2025 (year ended September 2025) was $9.1 million, up 163.5% from fiscal 2024.
- Revenue
- +16.3%
- EPS
- −27.8%
- Free cash flow
- +26.9%
Quarter to June 2026, against a year earlier
Follow NMTC
Alert me
NeuroOne Medical Technologies Corporation (NMTC) EV/Sales
As of 6 November 2026, NeuroOne Medical Technologies Corporation (NMTC) trades at a EV/Sales of 0.6×. Over the past ten years it has ranged from −22.9× (May 2022) to 192× (August 2022); the current reading is higher than 20% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.2× | (55.88%) |
| FY2024 | 7.3× | 60.65% |
| FY2023 | 4.5× | (39.82%) |
| FY2022 | 7.5× | (94.85%) |
| FY2021 | 146× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.6× | (35.83%) |
| Mar 2026 | 4.0× | 0.64% |
| Dec 2025 | 4.0× | 24.13% |
| Sep 2025 | 3.2× | (14.94%) |
| 20 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AEMD Aethlon Medical, Inc. compare | −2.7× |
| TBIO Telesis Bio Inc. compare | 0.1× |
| IRIX IRIDEX Corporation compare | 0.2× |
| INBS Intelligent Bio Solutions Inc. compare | 0.3× |
| NMTC NeuroOne Medical Technologies Corporation | 0.6× |
| BMRA Biomerica, Inc. compare | 0.6× |
| BTCY Biotricity Inc. compare | 1.7× |
| SINT SINTX TECHNOLOGIES, INC. compare | 2.6× |
| VNRX VolitionRX Limited compare | 4.1× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)